Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer

201277 citationsJournal Articlehybrid Open Access

Authors

H. Kröning · Praxis für Hämatologie und Onkologie

K. Possinger · Charité - Universitätsmedizin Berlin

Diana Lüftner · Charité - Universitätsmedizin Berlin

Abstract

This NIS reports one of the largest mCRC collectives >65 years and reduced performance status. Cetuximab has a similar efficacy and safety profile for pts aged ≤ 65 and >65 years.

Topics & Keywords

Colorectal Cancer Treatments and Studies Genetic factors in colorectal cancer Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Cancer

Volume 106, Issue 2, pp. 274-278

DOI: 10.1038/bjc.2011.554

Field-Weighted Citation Impact: 3.63